trifluridine tipiracil,regorafenib
bayer,servier,otsuka
[' 400p', ' 325p', '98p', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', ' 398p', 'regorafenib', 'trifluridine,tipiracil']
posters to look at #esmo2022: 325p early-onset #cc in the us trends in prevalence stage and survival 398p effectiveness + safety of regorafenib + trifluridine/tipiracil in #mcrc 400p regorafenib dose optimization in relapsed/refractory #mcrc #meded 
Independent and international experts in GI oncology supporting medical oncologists to give the best possible care to patients. Part of https://t.co/Y8pV8OaxOB